A. Markou

1.2k total citations
16 papers, 990 citations indexed

About

A. Markou is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, A. Markou has authored 16 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 5 papers in Cognitive Neuroscience. Recurrent topics in A. Markou's work include Neurotransmitter Receptor Influence on Behavior (12 papers), Neuroscience and Neuropharmacology Research (7 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). A. Markou is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (12 papers), Neuroscience and Neuropharmacology Research (7 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). A. Markou collaborates with scholars based in United States, United Kingdom and Switzerland. A. Markou's co-authors include George F. Koob, Neil E. Paterson, Manoranjan S. D’Souza, Svetlana Semenova, Mark P. Epping-Jordan, Andrew W. Stoker, Diego A. Pizzagalli, Andre Der‐Avakian, Samuel A. Barnes and Washington Pires and has published in prestigious journals such as Biological Psychiatry, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

A. Markou

16 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Markou United States 14 755 548 222 136 132 16 990
Roman Stefański Poland 22 961 1.3× 522 1.0× 298 1.3× 106 0.8× 177 1.3× 47 1.2k
Dev Chandra United States 16 1.0k 1.4× 490 0.9× 399 1.8× 109 0.8× 119 0.9× 20 1.3k
Tomohiro Abekawa Japan 19 957 1.3× 421 0.8× 287 1.3× 93 0.7× 121 0.9× 39 1.2k
Matthew C. Hearing United States 22 1.1k 1.4× 662 1.2× 330 1.5× 111 0.8× 110 0.8× 32 1.3k
Olga Vekovischeva Finland 18 734 1.0× 400 0.7× 257 1.2× 98 0.7× 84 0.6× 36 1.0k
Kelly J. Stanhope United Kingdom 14 799 1.1× 471 0.9× 307 1.4× 78 0.6× 120 0.9× 19 1.1k
Janel M. Boyce‐Rustay United States 17 578 0.8× 286 0.5× 169 0.8× 213 1.6× 153 1.2× 19 875
Michel M. M. Verheij Netherlands 18 555 0.7× 338 0.6× 199 0.9× 93 0.7× 94 0.7× 48 922
J.M. Delfs United States 9 934 1.2× 369 0.7× 188 0.8× 89 0.7× 129 1.0× 11 1.1k
Marek Schwendt United States 22 1.1k 1.5× 613 1.1× 321 1.4× 111 0.8× 212 1.6× 53 1.4k

Countries citing papers authored by A. Markou

Since Specialization
Citations

This map shows the geographic impact of A. Markou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Markou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Markou more than expected).

Fields of papers citing papers by A. Markou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Markou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Markou. The network helps show where A. Markou may publish in the future.

Co-authorship network of co-authors of A. Markou

This figure shows the co-authorship network connecting the top 25 collaborators of A. Markou. A scholar is included among the top collaborators of A. Markou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Markou. A. Markou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Grayson, Ben, et al.. (2015). Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review. Current topics in behavioral neurosciences. 29. 403–428. 37 indexed citations
2.
Barnes, Samuel A., António Pinto‐Duarte, Andreas Zembrzycki, et al.. (2015). Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders. Molecular Psychiatry. 20(10). 1161–1172. 63 indexed citations
3.
Der‐Avakian, Andre, Manoranjan S. D’Souza, Diego A. Pizzagalli, & A. Markou. (2013). Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research. Translational Psychiatry. 3(8). e297–e297. 83 indexed citations
4.
D’Souza, Manoranjan S. & A. Markou. (2013). The "Stop" and "Go" of Nicotine Dependence: Role of GABA and Glutamate. Cold Spring Harbor Perspectives in Medicine. 3(6). a012146–a012146. 60 indexed citations
5.
Stoker, Andrew W., Svetlana Semenova, & A. Markou. (2008). Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice. Neuropharmacology. 54(8). 1223–1232. 76 indexed citations
6.
Liechti, Matthias E., Ronald Kuczenski, & A. Markou. (2008). P.2.24 Glutamate and the reinforcing effects of nicotine. European Neuropsychopharmacology. 18. s56–s56. 1 indexed citations
7.
Markou, A.. (2005). S44 GABAERGIC AND GLUTAMATERGIC MECHANISMS OF NICOTINE DEPENDENCE. Behavioural Pharmacology. 16(Supplement 1). S14–S14. 1 indexed citations
8.
Kenny, Paul J., Neil E. Paterson, Benjamin Boutrel, et al.. (2003). Metabotropic Glutamate 5 Receptor Antagonist MPEP Decreased Nicotine and Cocaine Self‐Administration but Not Nicotine and Cocaine‐Induced Facilitation of Brain Reward Function in Rats. Annals of the New York Academy of Sciences. 1003(1). 415–418. 91 indexed citations
9.
10.
Markou, A. & Neil E. Paterson. (2001). The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine & Tobacco Research. 3(4). 361–373. 123 indexed citations
11.
Baldo, Brian A., et al.. (1999). A Dopamine D1 Agonist Elevates Self-Stimulation Thresholds. Pharmacology Biochemistry and Behavior. 62(4). 659–672. 24 indexed citations
12.
Epping-Jordan, Mark P., A. Markou, & George F. Koob. (1998). The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat. Brain Research. 784(1-2). 105–115. 99 indexed citations
13.
Whitelaw, Rachel B., Trevor W. Robbins, Barry J. Everitt, & A. Markou. (1996). Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology. 127(3). 213–224. 17 indexed citations
14.
Markou, A., K. Matthews, David H. Overstreet, George F. Koob, & M A Geyer. (1994). Flinders resistant hypocholinergic rats exhibit startle sensitization and reduced startle thresholds. Biological Psychiatry. 36(10). 680–688. 20 indexed citations
15.
Hammer, Ronald P., Washington Pires, A. Markou, & George F. Koob. (1993). Withdrawal following cocaine self‐administration decreases regional cerebral metabolic rate in critical brain reward regions. Synapse. 14(1). 73–80. 44 indexed citations
16.
Markou, A. & George F. Koob. (1992). Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations. Physiology & Behavior. 51(1). 111–119. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026